Fresenius Medical Care: Clanton, AL (Birmingham, MSA)

RARE 20-YEAR ORIGINAL LEASE TERM WITH ANNUAL CPI INCREASES
20-year (17-years remaining) Absolute NNN lease with annual CPI rent increases (1% floor, 2% max). There are an additional three, 5-Year Renewal Option Periods.

ABSOLUTE NNN LEASE
Unlike the standard dialysis center leases with significant Landlord responsibilities (such as roof, structure, parking lot and HVAC replacement), the Subject Property has an absolute NNN lease structure that provides an investor with a long-term, passive income stream with no landlord maintenance responsibilities whatsoever. (See Market Lease Comparison)

WELL-ESTABLISHED LOCATION IN BIRMINGHAM MSA
Fresenius has a 19-year operational history at this location and is the only dialysis center within a 25 mile radius. Known for being the state’s largest producer of peaches, Clanton is centrally located halfway between Birmingham and Montgomery off I-65 (38,975 ADT). The Birmingham metropolitan area boasts a population of more than 1,100,000 residents, 26 accredited universities and colleges enrolling 130,000+ students, producing over 20,000 prospective employees every year, a veteran workforce of more than 25,000 members, and a highly skilled labor force of 800,000 workers within 60 minutes of downtown. Greater Birmingham benefits from the 75+ healthcare companies in the region, 59,000 healthcare workers and groundbreaking research performed at the University of Alabama Birmingham (UAB). As Alabama’s largest employer, UAB generates more than $7 billion in economic impact annually and employs more than 23,000.

INVESTMENT GRADE LEASE GUARANTOR(1)
Fresenius Medical Care Holdings, Inc., the Guarantor under the Lease, has been rated “BBB/Stable” by S&P and carries a rating of “Baa3/Stable” from Moody’s, which are both Investment Grade according to each agency’s credit rating scales. This information must be verified by Buyer.

FRESENIUS MEDICAL CARE CORPORATE LEASE(1)
•Fresenius Medical Care reported $18.03 Billion in revenue (TTM Q3 2020) and a net worth of $13.2 Billion (2019)
•Fresenius Medical Care is the world’s largest provider of products and services for individuals with renal diseases of which nearly 3.5 Million patients worldwide regularly undergo dialysis treatment
•Fresenius Medical Care performed 52 Million dialysis treatments in 2019
•Every 0.6 seconds Fresenius Medical Care provides a dialysis treatment (2019)
•Fresenius Medical Care serves 349,000 patients in more than 50 countries across 4,000 clinics

(1) Fresenius Medical Care Holdings, Inc., the Guarantor under the Lease, has been rated “BBB/Stable” from S&P and carries a rating of “Baa3/Stable” from Moody’s, which are both Investment Grade according to each agency’s credit rating scales. This information must be verified by Buyer.
Sources: www.standardandpoors.com, www.moodys.com www.freseniusmedicalcare.com, Yahoo Finance

AL Broker of Record: Eddie Greenhalgh
License: 00008-8298